Heterogeneous Activation of Signaling Pathways and Therapeutic Vulnerabilities in KSHV‐Associated Primary Effusion Lymphoma Cell Lines is a research paper published in Journal of Medical Virology (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA096512
NCI NIH HHS
Grant: R01 CA291244
NCI NIH HHS
Grant: P30 CA047904
NCI NIH HHS
Grant: R01 CA124332
NCI NIH HHS
Grant: R01 CA278812
NCI NIH HHS
Grant: R01 CA284554
National Institutes of Health
Grant: 5R01CA096512-03
Cell Model for KSHV Infection and Genetic Manipulation
National Institutes of Health
Grant: 1R01CA291244-01A1
METTL16 and S-adenosylmethionine cycle in KSHV infection
National Institutes of Health
Grant: 5R01CA284554-03
Impact of microbiota on AIDS-Kaposi’s sarcoma development and therapy
National Institutes of Health
Grant: 5R01CA124332-08
Regulation of KSHV infection and replication by MAPK pathways
National Institutes of Health
Grant: 5R01CA278812-03
Citrulline-urea cycle in KSHV cellular transformation
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
This study was supported by grants from the National Institutes of Health (CA096512, CA284554, CA278812, CA291244 and CA124332 to Shou-Jiang Gao), UPMC Hillman Cancer Center Startup Fund to Shou-Jiang Gao, and in part by award P30CA047904.
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals